Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2013

01-03-2013 | Original Article

An observational study of foot ulceration risk in diabetic patients evaluated with autofluorescence: 195 cases cross-sectional and one-year outcome

Authors: Hang Hu, Xindong Jin, Hongfei Jiang, Xinlei Hu, Chunmao Han

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2013

Login to get access

Abstract

To determine the risk factors of foot ulcers in diabetic patients indirectly via the measurement of advanced glycation end-products (AGE) with autofluorescence (AF). Between 2008 and 2009, a total of 195 diabetic inpatients, were recruited. Patients were categorized into those without foot ulcer, or with foot ulcer. Patients were followed up for 1 year via telephone and hospital visit. According to the first screening, mean values of skin AF were:2.29 ± 0.47 for subjects without foot ulcers and 2.80 ± 0.69 for those with foot ulcers, a significant difference(P < 0.05). Follow-up was conducted via telephone in 149 patients, and there were no significant changes in disease condition of both groups. Additionally, 34 patients were further followed-up via hospital visit. Each variable of these patients after follow-up was closely related to the corresponding one before follow-up (P < 0.05). Glycosylated hemoglobin (HbA1c) levels markedly declined, and high-density lipoprotein (HDL) cholesterol levels and VPT were significantly increased, after follow-up (P < 0.05). Moreover, there were no significant changes in AF value and ABI during follow-up. AF, which is associated with in vivo AGE levels, is also closely related to various risk factors of foot ulcers in diabetic patients. Our follow-up duration was relatively short, and thus, more studies with longer follow-up periods are warranted to confirm the role of AF as a risk factor for foot ulcers in diabetic patients.
Literature
1.
go back to reference Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(5 Suppl):S1–66.PubMed Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(5 Suppl):S1–66.PubMed
2.
go back to reference Huijberts MS, Schaper NC, Schalkwijk CG. Advanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev. 2008;24 Suppl 1:S19–24.PubMedCrossRef Huijberts MS, Schaper NC, Schalkwijk CG. Advanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev. 2008;24 Suppl 1:S19–24.PubMedCrossRef
3.
go back to reference Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.PubMedCrossRef Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.PubMedCrossRef
4.
go back to reference Facchiano F, Lentini A, Fogliano V, Mancarella S, Rossi C, Facchiano A, et al. Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo. Am J Pathol. 2002;161:531–41.PubMedCrossRef Facchiano F, Lentini A, Fogliano V, Mancarella S, Rossi C, Facchiano A, et al. Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo. Am J Pathol. 2002;161:531–41.PubMedCrossRef
5.
go back to reference Portero-Otin M, Pamplona R, Bellmunt MJ, Ruiz MC, Prat J, Salvayre R, et al. Advanced glycation end product precursors impair epidermal growth factor receptor signaling. Diabetes. 2002;51:1535–42.PubMedCrossRef Portero-Otin M, Pamplona R, Bellmunt MJ, Ruiz MC, Prat J, Salvayre R, et al. Advanced glycation end product precursors impair epidermal growth factor receptor signaling. Diabetes. 2002;51:1535–42.PubMedCrossRef
6.
go back to reference Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol. 2001;159:513–25.PubMedCrossRef Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol. 2001;159:513–25.PubMedCrossRef
7.
go back to reference Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes. 2003;52:2805–13.PubMedCrossRef Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes. 2003;52:2805–13.PubMedCrossRef
Metadata
Title
An observational study of foot ulceration risk in diabetic patients evaluated with autofluorescence: 195 cases cross-sectional and one-year outcome
Authors
Hang Hu
Xindong Jin
Hongfei Jiang
Xinlei Hu
Chunmao Han
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2013
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-012-0098-7

Other articles of this Issue 1/2013

International Journal of Diabetes in Developing Countries 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.